Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1953 1
1954 1
1955 1
1957 1
1965 1
1973 1
1976 3
1977 1
1978 1
1989 1
1990 1
1996 2
1997 3
1998 3
1999 2
2000 4
2001 1
2003 1
2004 2
2005 5
2006 2
2007 4
2008 8
2009 3
2010 8
2011 13
2012 21
2013 14
2014 19
2015 24
2016 40
2017 38
2018 25
2019 15
2020 25
2021 23
2022 28
2023 29
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Results by year

Filters applied: . Clear all
Page 1
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D'Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Schito M, et al. Among authors: d ambrosio l. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S102-18. doi: 10.1093/cid/civ609. Clin Infect Dis. 2015. PMID: 26409271 Free PMC article.
Drug resistant TB - latest developments in epidemiology, diagnostics and management.
Tiberi S, Utjesanovic N, Galvin J, Centis R, D'Ambrosio L, van den Boom M, Zumla A, Migliori GB. Tiberi S, et al. Among authors: d ambrosio l. Int J Infect Dis. 2022 Nov;124 Suppl 1:S20-S25. doi: 10.1016/j.ijid.2022.03.026. Epub 2022 Mar 25. Int J Infect Dis. 2022. PMID: 35342000 Free article. Review.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017; Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilb… See abstract for full author list ➔ Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, et al. Among authors: d ambrosio l. Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Lancet. 2018. PMID: 30215381 Free PMC article. Review.
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, Muñoz Torrico M, Duarte R, Alffenaar JW, Schaaf HS, Marais BJ, Cirillo DM, Alagna R, Rendon A, Pontali E, Piubello A, Figueroa J, Ferlazzo G, García-Basteiro A, Centis R, Visca D, D'Ambrosio L, Sotgiu G; members of the Global Tuberculosis Network. Migliori GB, et al. Among authors: d ambrosio l. Int J Infect Dis. 2020 Mar;92S:S15-S25. doi: 10.1016/j.ijid.2020.01.042. Epub 2020 Feb 4. Int J Infect Dis. 2020. PMID: 32032752 Free article. Review.
Multidrug-resistant tuberculosis today.
Matteelli A, Centis R, D'Ambrosio L, Migliori GB. Matteelli A, et al. Among authors: d ambrosio l. Bull World Health Organ. 2012 Feb 1;90(2):78. doi: 10.2471/BLT.11.097360. Bull World Health Organ. 2012. PMID: 22423153 Free PMC article. No abstract available.
Tuberculosis elimination: where are we now?
Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, Centis R, D'Ambrosio L, Visca D, Spanevello A, Battista Migliori G. Matteelli A, et al. Among authors: d ambrosio l. Eur Respir Rev. 2018 Jun 13;27(148):180035. doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30. Eur Respir Rev. 2018. PMID: 29898905 Free PMC article. Review.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
D'Ambrosio L, Touati N, Blay JY, Grignani G, Flippot R, Czarnecka AM, Piperno-Neumann S, Martin-Broto J, Sanfilippo R, Katz D, Duffaud F, Vincenzi B, Stark DP, Mazzeo F, Tuchscherer A, Chevreau C, Sherriff J, Estival A, Litière S, Sents W, Ray-Coquard I, Tolomeo F, Le Cesne A, Rutkowski P, Stacchiotti S, Kasper B, Gelderblom H, Gronchi A; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. D'Ambrosio L, et al. Cancer. 2020 Jun 1;126(11):2637-2647. doi: 10.1002/cncr.32795. Epub 2020 Mar 4. Cancer. 2020. PMID: 32129883 Free article.
Planning for TB elimination in Lebanon.
Yaacoub H, Farhat AM, Najjar-Pellet J, Zgheib J, Jradi F, van den Boom M, D Ambrosio L, Centis R, Migliori GB. Yaacoub H, et al. Among authors: d ambrosio l. Int J Tuberc Lung Dis. 2023 Mar 1;27(3):171-174. doi: 10.5588/ijtld.22.0673. Int J Tuberc Lung Dis. 2023. PMID: 36855041 No abstract available.
Tuberculosis Elimination: Myth or Achievable Target?
Centis R, D'Ambrosio L, Kurhasani X, Solovic I, Migliori GB. Centis R, et al. Among authors: d ambrosio l. Arch Bronconeumol. 2023 Nov;59(11):714-716. doi: 10.1016/j.arbres.2023.09.002. Epub 2023 Sep 18. Arch Bronconeumol. 2023. PMID: 37838537 English, Spanish. No abstract available.
348 results